Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Kinnevik B

Kinnevik B

82,88SEK
−1,50% (−1,26)
Päätöskurssi
Ylin84,64
Alin82,42
Vaihto
93,2 MSEK
82,88SEK
−1,50% (−1,26)
Päätöskurssi
Ylin84,64
Alin82,42
Vaihto
93,2 MSEK

Kinnevik B

Kinnevik B

82,88SEK
−1,50% (−1,26)
Päätöskurssi
Ylin84,64
Alin82,42
Vaihto
93,2 MSEK
82,88SEK
−1,50% (−1,26)
Päätöskurssi
Ylin84,64
Alin82,42
Vaihto
93,2 MSEK

Kinnevik B

Kinnevik B

82,88SEK
−1,50% (−1,26)
Päätöskurssi
Ylin84,64
Alin82,42
Vaihto
93,2 MSEK
82,88SEK
−1,50% (−1,26)
Päätöskurssi
Ylin84,64
Alin82,42
Vaihto
93,2 MSEK
Q3-osavuosiraportti
23 päivää sitten49 min

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
240 275
Myynti
Määrä
243 820

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
10--
1 512--
1 482--
1 174--
10--
Ylin
84,64
VWAP
83,22
Alin
82,42
VaihtoMäärä
93,2 1 119 894
VWAP
83,22
Ylin
84,64
Alin
82,42
VaihtoMäärä
93,2 1 119 894

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4-osavuosiraportti
3.2.2026
Menneet tapahtumat
2025 Q3-osavuosiraportti16.10.
2025 Q2-osavuosiraportti8.7.
2024 Yhtiökokous12.5.
2025 Q1-osavuosiraportti24.4.
2024 Q4-osavuosiraportti4.2.
Datan lähde: Millistream, Quartr

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    This is just terribly bad right now! How on earth can it just keep going south? I do believe in the company and will average down, but this is so disappointing!
  • 27.10.
    ·
    27.10.
    ·
    I calculate the real net asset discount exclusively in relation to the unlisted shares, as I first offset the value of the listed shares and liquid positive capital in full (and offset any debt.) I have made this comparison of the small First Venture and the large Kinnevik. The official net asset discount in First Venture is approx. 65%. But that is not how I calculate it. The real net asset discount is a good 75%. I calculate the real net asset discount exclusively in relation to the unlisted shares, as I first offset the value of the listed shares and liquid positive capital in full (and offset any debt.) Then, of course, it is necessary to look at what unlisted shares are in the company's portfolio. First, you have to consider whether the value has been determined correctly. I do not have the prerequisites to know this, and must therefore assess whether I find the management credible and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further. (Although the latter is the case in this share – and is basically positive – I have written previously that in this share in particular I may be a little concerned about whether it might one day lead to a takeover and redemption of the small shareholders if the small shareholders continuously part with this share.) Partly, one must consider the security in relation to how much individual shares occupy in the portfolio. In this share, the 3 largest unlisted companies together constitute “only” approximately 50% of the unlisted shares. So that does not worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact in relation to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And this must of course be included in the overall assessment. For comparison, Umecrine alone accounts for almost 55% of the unlisted shares in Karolinska Development (which I also invest in), which some believe is the reason for the large discount to net worth in this company of approximately 80%. But also in Karolinska Development, the large discount to net worth more than adequately takes into account if Umecrine were to be worth 0 kr. against expectations. I have tried using the same method to assess the real discount to net worth in Kinnevik (which is currently rising sharply in value) compared to First Venture. The official discount to net worth is approximately 35%. The real discount to net worth is approximately 45% according to my calculation. At Kinnevik, the 3 largest unlisted companies account for approximately 43% of the unlisted shares, and are quite similar to First Venture in this respect. But the portfolio is broader in Kinnevik – and the share capital is of a completely different size, and the administrative expenses as a percentage of the market value are correspondingly much lower. My confidence in the management, on the other hand, is not very high, as I continue to wonder about the logic of selling the golden egg and now instead having 7.7 billion in uninvested capital, instead of having continuously sold out of the golden egg when there was a need for it and there were companies in which they would rather invest the money. But others may be more capable than me of assessing the value of the underlying unlisted companies in the three listed companies mentioned.
  • 27.10.
    ·
    27.10.
    ·
    What does the Stegra holding look like, how much would a bankruptcy there affect you?
    27.10.
    ·
    27.10.
    ·
    I'm not worried about that. I'm more worried that they'll put even more money into that project. All else being equal, I'd buy a lot of shares, but if they go in with more money, I don't want to be on the trip.
  • 25.10.
    ·
    25.10.
    ·
    Everyone loves Kinnevik, even DI.
  • 16.10.
    16.10.
    Minä vaan roikun tuohon reiluun 100 kurssiin. Niin pienillä panoksilla tässä kiinni, että riittää pieni voitto. Jostain syystä tämä arvo-osuustilillä... Voitostakaan ei mitään hyötyä. Surkea sijoituspäätös.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

Q3-osavuosiraportti
23 päivää sitten49 min

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    This is just terribly bad right now! How on earth can it just keep going south? I do believe in the company and will average down, but this is so disappointing!
  • 27.10.
    ·
    27.10.
    ·
    I calculate the real net asset discount exclusively in relation to the unlisted shares, as I first offset the value of the listed shares and liquid positive capital in full (and offset any debt.) I have made this comparison of the small First Venture and the large Kinnevik. The official net asset discount in First Venture is approx. 65%. But that is not how I calculate it. The real net asset discount is a good 75%. I calculate the real net asset discount exclusively in relation to the unlisted shares, as I first offset the value of the listed shares and liquid positive capital in full (and offset any debt.) Then, of course, it is necessary to look at what unlisted shares are in the company's portfolio. First, you have to consider whether the value has been determined correctly. I do not have the prerequisites to know this, and must therefore assess whether I find the management credible and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further. (Although the latter is the case in this share – and is basically positive – I have written previously that in this share in particular I may be a little concerned about whether it might one day lead to a takeover and redemption of the small shareholders if the small shareholders continuously part with this share.) Partly, one must consider the security in relation to how much individual shares occupy in the portfolio. In this share, the 3 largest unlisted companies together constitute “only” approximately 50% of the unlisted shares. So that does not worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact in relation to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And this must of course be included in the overall assessment. For comparison, Umecrine alone accounts for almost 55% of the unlisted shares in Karolinska Development (which I also invest in), which some believe is the reason for the large discount to net worth in this company of approximately 80%. But also in Karolinska Development, the large discount to net worth more than adequately takes into account if Umecrine were to be worth 0 kr. against expectations. I have tried using the same method to assess the real discount to net worth in Kinnevik (which is currently rising sharply in value) compared to First Venture. The official discount to net worth is approximately 35%. The real discount to net worth is approximately 45% according to my calculation. At Kinnevik, the 3 largest unlisted companies account for approximately 43% of the unlisted shares, and are quite similar to First Venture in this respect. But the portfolio is broader in Kinnevik – and the share capital is of a completely different size, and the administrative expenses as a percentage of the market value are correspondingly much lower. My confidence in the management, on the other hand, is not very high, as I continue to wonder about the logic of selling the golden egg and now instead having 7.7 billion in uninvested capital, instead of having continuously sold out of the golden egg when there was a need for it and there were companies in which they would rather invest the money. But others may be more capable than me of assessing the value of the underlying unlisted companies in the three listed companies mentioned.
  • 27.10.
    ·
    27.10.
    ·
    What does the Stegra holding look like, how much would a bankruptcy there affect you?
    27.10.
    ·
    27.10.
    ·
    I'm not worried about that. I'm more worried that they'll put even more money into that project. All else being equal, I'd buy a lot of shares, but if they go in with more money, I don't want to be on the trip.
  • 25.10.
    ·
    25.10.
    ·
    Everyone loves Kinnevik, even DI.
  • 16.10.
    16.10.
    Minä vaan roikun tuohon reiluun 100 kurssiin. Niin pienillä panoksilla tässä kiinni, että riittää pieni voitto. Jostain syystä tämä arvo-osuustilillä... Voitostakaan ei mitään hyötyä. Surkea sijoituspäätös.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
240 275
Myynti
Määrä
243 820

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
10--
1 512--
1 482--
1 174--
10--
Ylin
84,64
VWAP
83,22
Alin
82,42
VaihtoMäärä
93,2 1 119 894
VWAP
83,22
Ylin
84,64
Alin
82,42
VaihtoMäärä
93,2 1 119 894

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4-osavuosiraportti
3.2.2026
Menneet tapahtumat
2025 Q3-osavuosiraportti16.10.
2025 Q2-osavuosiraportti8.7.
2024 Yhtiökokous12.5.
2025 Q1-osavuosiraportti24.4.
2024 Q4-osavuosiraportti4.2.
Datan lähde: Millistream, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

Q3-osavuosiraportti
23 päivää sitten49 min

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4-osavuosiraportti
3.2.2026
Menneet tapahtumat
2025 Q3-osavuosiraportti16.10.
2025 Q2-osavuosiraportti8.7.
2024 Yhtiökokous12.5.
2025 Q1-osavuosiraportti24.4.
2024 Q4-osavuosiraportti4.2.
Datan lähde: Millistream, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    This is just terribly bad right now! How on earth can it just keep going south? I do believe in the company and will average down, but this is so disappointing!
  • 27.10.
    ·
    27.10.
    ·
    I calculate the real net asset discount exclusively in relation to the unlisted shares, as I first offset the value of the listed shares and liquid positive capital in full (and offset any debt.) I have made this comparison of the small First Venture and the large Kinnevik. The official net asset discount in First Venture is approx. 65%. But that is not how I calculate it. The real net asset discount is a good 75%. I calculate the real net asset discount exclusively in relation to the unlisted shares, as I first offset the value of the listed shares and liquid positive capital in full (and offset any debt.) Then, of course, it is necessary to look at what unlisted shares are in the company's portfolio. First, you have to consider whether the value has been determined correctly. I do not have the prerequisites to know this, and must therefore assess whether I find the management credible and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further. (Although the latter is the case in this share – and is basically positive – I have written previously that in this share in particular I may be a little concerned about whether it might one day lead to a takeover and redemption of the small shareholders if the small shareholders continuously part with this share.) Partly, one must consider the security in relation to how much individual shares occupy in the portfolio. In this share, the 3 largest unlisted companies together constitute “only” approximately 50% of the unlisted shares. So that does not worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact in relation to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And this must of course be included in the overall assessment. For comparison, Umecrine alone accounts for almost 55% of the unlisted shares in Karolinska Development (which I also invest in), which some believe is the reason for the large discount to net worth in this company of approximately 80%. But also in Karolinska Development, the large discount to net worth more than adequately takes into account if Umecrine were to be worth 0 kr. against expectations. I have tried using the same method to assess the real discount to net worth in Kinnevik (which is currently rising sharply in value) compared to First Venture. The official discount to net worth is approximately 35%. The real discount to net worth is approximately 45% according to my calculation. At Kinnevik, the 3 largest unlisted companies account for approximately 43% of the unlisted shares, and are quite similar to First Venture in this respect. But the portfolio is broader in Kinnevik – and the share capital is of a completely different size, and the administrative expenses as a percentage of the market value are correspondingly much lower. My confidence in the management, on the other hand, is not very high, as I continue to wonder about the logic of selling the golden egg and now instead having 7.7 billion in uninvested capital, instead of having continuously sold out of the golden egg when there was a need for it and there were companies in which they would rather invest the money. But others may be more capable than me of assessing the value of the underlying unlisted companies in the three listed companies mentioned.
  • 27.10.
    ·
    27.10.
    ·
    What does the Stegra holding look like, how much would a bankruptcy there affect you?
    27.10.
    ·
    27.10.
    ·
    I'm not worried about that. I'm more worried that they'll put even more money into that project. All else being equal, I'd buy a lot of shares, but if they go in with more money, I don't want to be on the trip.
  • 25.10.
    ·
    25.10.
    ·
    Everyone loves Kinnevik, even DI.
  • 16.10.
    16.10.
    Minä vaan roikun tuohon reiluun 100 kurssiin. Niin pienillä panoksilla tässä kiinni, että riittää pieni voitto. Jostain syystä tämä arvo-osuustilillä... Voitostakaan ei mitään hyötyä. Surkea sijoituspäätös.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

SwedenNasdaq Stockholm
Määrä
Osto
240 275
Myynti
Määrä
243 820

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
10--
1 512--
1 482--
1 174--
10--
Ylin
84,64
VWAP
83,22
Alin
82,42
VaihtoMäärä
93,2 1 119 894
VWAP
83,22
Ylin
84,64
Alin
82,42
VaihtoMäärä
93,2 1 119 894

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt